Pfizer Cash Flow from Operations

PFE
 Stock
  

USD 51.88  0.29  0.56%   

Pfizer Inc fundamentals help investors to digest information that contributes to Pfizer's financial success or failures. It also enables traders to predict the movement of Pfizer Stock. The fundamental analysis module provides a way to measure Pfizer's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Pfizer stock. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
  
Refresh
The current year Net Cash Flow from Operations is expected to grow to about 17.8 B. The current year Free Cash Flow is expected to grow to about 10.7 B.

Pfizer Cash Flow from Operations Analysis

Pfizer's Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
 2019 2021 2022 (projected)
Consolidated Income16.3 B18.75 B17.02 B
Direct Expenses10.22 B10 B11.85 B
Operating Cash Flow 
 = 
EBITDA 
-  
Taxes 
More About Cash Flow from Operations | All Equity Analysis

Current Pfizer Cash Flow from Operations

    
  32.58 B  
Most of Pfizer's fundamental indicators, such as Cash Flow from Operations, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pfizer Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Pfizer Cash Flow from Operations Driver Correlations

Understanding the fundamental principles of building solid financial models for Pfizer is extremely important. It helps to project a fair market value of Ford stock properly, considering its historical fundamentals such as Cash Flow from Operations. Since Pfizer's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Pfizer's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Pfizer's interrelated accounts and indicators.

Pfizer Cash Flow from Operations Historical Pattern

Today, most investors in Pfizer Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Pfizer's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's cash flow from operations growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Pfizer cash flow from operations as a starting point in their analysis.
 Pfizer Cash Flow from Operations 
Share
      Timeline 
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
Compare to competition

Pfizer Net Loss Income from Discontinued Operations

Net Loss Income from Discontinued Operations

(4.96 Million)

Share
Pfizer Net Loss Income from Discontinued Operations is projected to increase significantly based on the last few years of reporting. The past year's Net Loss Income from Discontinued Operations was at (4.6 Million)
In accordance with the recently published financial statements, Pfizer Inc has 32.58 B in Cash Flow from Operations. This is much higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The cash flow from operations for all United States stocks is significantly lower than that of the firm.

Pfizer Cash Flow from Operations Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pfizer's direct or indirect competition against its Cash Flow from Operations to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Pfizer could also be used in its relative valuation, which is a method of valuing Pfizer by comparing valuation metrics of similar companies.
Pfizer is currently under evaluation in cash flow from operations category among related companies.

Pfizer Current Valuation Drivers

We derive many important indicators used in calculating different scores of Pfizer from analyzing Pfizer's financial statements. These drivers represent accounts that assess Pfizer's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Pfizer's important valuation drivers and their relationship over time.
201720182019202020212022 (projected)
Net Income Per Employee236.23 K120.7 K184.29 K122.16 K109.95 K116.77 K
Revenue Per Employee582.55 K580.6 K586.07 K532.4 K612.26 K665.93 K
Average Assets170.91 B170.32 B164.21 B162.39 B146.15 B149.93 B
Earnings Before Interest Taxes and Depreciation Amortization EBITDA17.94 B17.76 B23.64 B12.31 B14.16 B17.5 B
Earnings Before Interest Taxes and Depreciation Amortization USD14.1 B18.53 B18.24 B23.67 B21.3 B19.62 B
Earnings before Tax8.34 B12.26 B11.86 B17.66 B20.31 B18.49 B
Average Equity62.17 B62.22 B68.67 B61.66 B55.49 B59.93 B
Enterprise Value239.08 B257.07 B289.8 B266.7 B306.71 B295.03 B
Free Cash Flow14.19 B14.59 B13.63 B9.99 B8.99 B10.72 B
Invested Capital72.89 B78.83 B79.54 B87.01 B78.31 B80.24 B
Invested Capital Average79.13 B77.76 B73.71 B84.26 B75.84 B79.17 B
Market Capitalization197.1 B215.9 B252.32 B216.83 B249.35 B242.51 B
Tangible Asset Value64.52 B67.1 B70.8 B73.47 B66.12 B70.04 B
Working Capital7.83 B10.71 B18.07 B(4.5 B)(4.05 B)(4.16 B)

Pfizer Fundamentals

About Pfizer Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Pfizer Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pfizer using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pfizer Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2022
Net Cash Flow from Operations16.6 B17.8 B
Free Cash FlowB10.7 B
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. Pfizer operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. It employs 79000 people.

Pfizer Investors Sentiment

The influence of Pfizer's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Pfizer. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Pfizer Implied Volatility

    
  36.07  
Pfizer's implied volatility exposes the market's sentiment of Pfizer Inc stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Pfizer's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Pfizer stock will not fluctuate a lot when Pfizer's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Pfizer in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Pfizer's short interest history, or implied volatility extrapolated from Pfizer options trading.

Current Sentiment - PFE

Pfizer Inc Investor Sentiment

Predominant part of Macroaxis users are at this time bullish on Pfizer Inc. What is your perspective on investing in Pfizer Inc? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish

Currently Active Assets on Macroaxis

Please check Pfizer Piotroski F Score and Pfizer Altman Z Score analysis. Note that the Pfizer Inc information on this page should be used as a complementary analysis to other Pfizer's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Complementary Tools for Pfizer Stock analysis

When running Pfizer Inc price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Is Pfizer's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pfizer. If investors know Pfizer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pfizer listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
0.59
Market Capitalization
289.5 B
Quarterly Revenue Growth YOY
0.77
Return On Assets
0.12
Return On Equity
0.34
The market value of Pfizer Inc is measured differently than its book value, which is the value of Pfizer that is recorded on the company's balance sheet. Investors also form their own opinion of Pfizer's value that differs from its market value or its book value, called intrinsic value, which is Pfizer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pfizer's market value can be influenced by many factors that don't directly affect Pfizer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pfizer's value and its price as these two are different measures arrived at by different means. Investors typically determine Pfizer value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pfizer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.